Multiple Steroidogenic Factor 1 Binding Elements in the Human Steroidogenic Acute Regulatory Protein Gene 5'-flanking Region Are Required for Maximal Promoter Activity and Cyclic AMP Responsiveness
Overview
Affiliations
A proximal element from the human StAR gene promoter, containing the sequence (-105)TATCCTTGAC(-95), was shown to confer responsiveness to 8-Br-cAMP in the presence of steroidogenic factor 1 (SF-1) when placed behind a minimal thymidine kinase promoter or an SV40 promoter and transfected into BeWo cells which normally lack StAR and SF-1. This element was also transactivated by SF-1 in a yeast one-hybrid system. The -105 to -95 sequence was protected by SF-1 in footprint analysis and a double-stranded oligonucleotide containing the element bound SF-1 specifically in electrophoretic mobility shift assays. Another SF-1-binding sequence 35 bp upstream of the transcription start site ((-42)CAGCCTTC(-35)) was identified in the DNase 1 footprint analysis and, when mutated, markedly reduced SF-1-dependent and 8-Br-cAMP-stimulated StAR promoter activity in BeWo cells. The two proximal SF-1 response elements were shown to be critical for StAR promoter function in human granulosalutein cells, which express SF-1 and respond to cAMP with increased transcription of the StAR gene. Mutation of either element substantially reduced basal and forskolin-stimulated promoter activity, although mutation of the -105 to -95 element had more pronounced effects. Mutation of a third, more distal, SF-1-binding site at -926 to -918 also reduced basal but not forskolin-stimulated promoter activity in the granulosa-lutein cells. These findings demonstrate that multiple SF-1 response elements are required for maximal StAR promoter activity and regulation by cAMP.
Adolescent exposure to low-dose Δ9-tetrahydrocannabinol depletes the ovarian reserve in female mice.
Lim J, Lee H, Nguyen J, Shin J, Getze S, Quach C Toxicol Sci. 2023; 193(1):31-47.
PMID: 36912754 PMC: 10176244. DOI: 10.1093/toxsci/kfad027.
Pubertal development in 46,XY patients with NR5A1 mutations.
Monig I, Schneidewind J, Johannsen T, Juul A, Werner R, Lunstedt R Endocrine. 2021; 75(2):601-613.
PMID: 34613524 PMC: 8816419. DOI: 10.1007/s12020-021-02883-y.
Dog Steroidogenic Factor-1: Molecular cloning and analysis of epigenetic regulation.
Sekiya A, Takasawa K, Arai Y, Torisu S, Nishino K J Vet Med Sci. 2020; 82(6):681-689.
PMID: 32238671 PMC: 7324831. DOI: 10.1292/jvms.20-0050.
Teeli A, Leszczynski P, Krishnaswamy N, Ogawa H, Tsuchiya M, Smiech M Front Endocrinol (Lausanne). 2019; 10:748.
PMID: 31803139 PMC: 6877548. DOI: 10.3389/fendo.2019.00748.
Smith L, Huang V, Olah M, Trinh L, Liu Y, Hazell G Mol Cell Endocrinol. 2019; 499:110612.
PMID: 31604124 PMC: 6899503. DOI: 10.1016/j.mce.2019.110612.